Lund, Sweden

Neurovive Pharmaceutical Ab


USPTO Granted Patents = 7

% Expired Patents = 14.3



Trademarks = 4

Forward Citations = 10

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Steven James Moss (6 out of 29 patents)

silverMedal Matthew Alan Gregory (5 out of 18 patents)

bronzeMedal Barrie Wilkinson (4 out of 13 patents)

4.  Christine Janet Martin (2 out of 7 patents)

5.  Magnus Joakim Hansson (1 out of 6 patents)

6.  Karl Henrik Johannes Ehinger (1 out of 3 patents)

7.  Sarah Piel (1 out of 1 patent)

8.  Steven Gary Kendrew (1 out of 5 patents)

9.  Eskil Elmér (1 out of 2 patents)

10.  Eskil Mats Elmer (1 out of 4 patents)

11.  Derek Gregory Batcheller (1 patent)

12.  Rhonan Lee Ford (4 patents)

13.  Hans Georg Fliri (3 patents)

14.  David Arthur Scowen (1 patent)

15.  Fredrik Sjövall (0 patent)


7 patents:

Company Overview
NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with a focus on developing treatments for acute cardiovascular and neurological conditions. The company's research is targeted towards developing compounds that target mitochondrial dysfunction, aiming to address unmet medical needs in diseases such as traumatic brain injury and heart failure.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#60 in Lund

#812 in Sweden

Lund, SE
Lund, Sweden
Forward Citations = 10

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neurovive Pharmaceutical Ab. Retrieved from https://idiyas.com/company/neurovive-pharmaceutical-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…